Peripheral Neuropathy: Clinical Trials

7 trials for Peripheral Neuropathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 7
Phase 25Completed 5

Follow Peripheral Neuropathy: new trials by email Literature Review of Peripheral Neuropathy trials Research Report on Peripheral Neuropathy

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Cilostazol in Prevention of Peripheral Neuropathy
Cilostazol, Placebo - Peripheral Neuropathy, Breast Cancer
Phase 1 / Phase 2CompletedMansoura University712022-03-282023-03-15
Xanamemâ„¢ in Healthy Elderly Subjects
Xanamem, Matching Placebo - Safety, Peripheral Neuropathy
Phase 1CompletedActinogen Medical422019-01-212025-01-22
L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients
L-CARNOSINE - Peripheral Neuropathy, Cancer
Phase 1 / Phase 2CompletedCairo University652015-06-012017-04-24
Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy
Alpha lipoic acid - Peripheral Neuropathy
Phase 1 / Phase 2CompletedNorthwestern University92012-02-012014-10-02
Effects of Vaporized Marijuana on Neuropathic Pain
Mild dose cannabis, Low dose cannabis, Cannabis - Neuropathic Pain, Reflex Sympathetic Dystrophy
Phase 1 / Phase 2CompletedUniversity of California, Davis442009-12-012018-01-31
Painful HIV Neuropathy and Alpha-Lipoic Acid
Alpha-Lipoic Acid - HIV, Peripheral Neuropathy
Phase 1 / Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)602003-09-012008-04-22
Achilles Tendon Lengthening in Patients With Diabetes to Prevent Foot Ulcers
Achilles tendon-lengthening surgery - Diabetes Mellitus, Foot Ulcer
Phase 1CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)601998-08-012005-06-24

Narrower conditions

Peripheral Nervous System Diseases (7)  ·  Breast Neoplasms (2)  ·  Diabetes Mellitus (1)  ·  Foot Deformities (1)  ·  Foot Ulcer (1)  ·  Marijuana Abuse (1)  ·  Multiple Sclerosis (1)  ·  Neoplasms (1)  ·  Neuralgia (1)  ·  Neuralgia, Postherpetic (1)  ·  Reflex Sympathetic Dystrophy (1)  ·  Small Fiber Neuropathy (1)  ·  Spinal Cord Injuries (1)

Broader conditions

Nervous System Diseases (7)  ·  Neuromuscular Diseases (7)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Breast Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Autonomic Nervous System Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Complex Regional Pain Syndromes (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)

Interventions

Thioctic Acid (2)  ·  Carnosine (1)  ·  Cilostazol (1)  ·  UE2343 (1)  ·  nabiximols (1)

Sponsors

Actinogen Medical (1)  ·  Cairo University (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Mansoura University (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  Northwestern University (1)  ·  University of California, Davis (1)

Countries

United States (4)  ·  Egypt (2)  ·  Australia (1)

Top investigators

Amr Shafik, Assoc. Prof (1)  ·  Barth L Wilsey, MD (1)  ·  Bill Ketelbey, MD (1)  ·  Jeffrey A. Allen, MD (1)  ·  John Mann, MD (1)  ·  Michael J. Mueller, Ph.D., P.T. (1)  ·  Mona Schaalan, assoc. prof. (1)  ·  Samira Saleh, Professor (1)

NIH funding

R01HD036802 (1)